Literature DB >> 24654945

When should we use partially hydrolysed formulae for frequent gastrointestinal symptoms and allergy prevention?

Y Vandenplas1, S Cruchet, C Faure, Hc Lee, C Di Lorenzo, A Staiano, Xu Chundi, Mm Aw, P Gutiérrez-Castrellón, A Asery, J Spolidoro, Rg Heine, M Miqdady, Me Arancibia, P Alarcón.   

Abstract

UNLABELLED: Experts reviewed the literature to determine whether partially whey hydrolysed formulas (HF) offer benefits in the dietary management of frequent gastrointestinal symptoms and allergy prevention. Compared with standard cow's milk-based formulas, partially whey HF confer a limited protective effect against allergic disease in high-risk infants, particularly atopic dermatitis, but not respiratory allergies. No randomised clinical trials have been published on partially whey HF in infants with colicky symptoms. The group did not find sufficient evidence to support the use of partially whey HF in regurgitation, although recent data suggest that a thickened partially whey HF may be more effective. Partially whey HF, fortified with prebiotics and/or probiotics, with high levels of sn-2 palmitate in the fat blend or without palm oil, provide some benefit in functional constipation.
CONCLUSION: Overall, partially whey HF may offer a useful alternative to intact protein in the dietary management of common functional gastrointestinal symptoms. ©2014 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Cow milk (protein) allergy; Extensive hydrolysate; Hydrolysate; Hypo-allergenic formula; partially hydrolysate

Mesh:

Substances:

Year:  2014        PMID: 24654945     DOI: 10.1111/apa.12637

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  7 in total

1.  Influence of Bovine Whey Protein Concentrate and Hydrolysate Preparation Methods on Motility in the Isolated Rat Distal Colon.

Authors:  Julie E Dalziel; Rachel C Anderson; Shalome A Bassett; Catherine M Lloyd-West; Neill W Haggarty; Nicole C Roy
Journal:  Nutrients       Date:  2016-12-14       Impact factor: 5.717

2.  Effect of a Partially Hydrolysed Whey Infant Formula Supplemented with Starch and Lactobacillus reuteri DSM 17938 on Regurgitation and Gastric Motility.

Authors:  Flavia Indrio; Giuseppe Riezzo; Paola Giordano; Maria Ficarella; Maria Paola Miolla; Silvia Martini; Luigi Corvaglia; Ruggiero Francavilla
Journal:  Nutrients       Date:  2017-10-28       Impact factor: 5.717

Review 3.  Prevention and Management of Cow's Milk Allergy in Non-Exclusively Breastfed Infants.

Authors:  Yvan Vandenplas
Journal:  Nutrients       Date:  2017-07-10       Impact factor: 5.717

4.  Digestive Responses to Fortified Cow or Goat Dairy Drinks: A Randomised Controlled Trial.

Authors:  Amber M Milan; Alison J Hodgkinson; Sarah M Mitchell; Utpal K Prodhan; Colin G Prosser; Elizabeth A Carpenter; Karl Fraser; David Cameron-Smith
Journal:  Nutrients       Date:  2018-10-12       Impact factor: 5.717

5.  A Partially Hydrolyzed Whey Infant Formula Supports Appropriate Growth: A Randomized Controlled Non-Inferiority Trial.

Authors:  Eva Karaglani; Inge Thijs-Verhoeven; Marjan Gros; Christina Chairistanidou; Giorgos Zervas; Christina Filoilia; Tarek-Michail Kampani; Vasileios Miligkos; Maria Matiatou; Stavroula Valaveri; Alexandros Sakellariou; Georgios Babilis; Rolf Bos; Yannis Manios
Journal:  Nutrients       Date:  2020-10-06       Impact factor: 5.717

6.  A new partially hydrolyzed whey-based follow-on formula with age-adapted protein content supports healthy growth during the first year of life.

Authors:  Claude Billeaud; Latif Adamon; Hugues Piloquet; Nicholas P Hays; Lénaïck Dupuis; Isabelle Metreau; André Léké
Journal:  Front Pediatr       Date:  2022-09-28       Impact factor: 3.569

Review 7.  Nutritional Aspects of Pediatric Gastrointestinal Diseases.

Authors:  Teresa Di Chio; Christiane Sokollik; Diego G Peroni; Lara Hart; Giacomo Simonetti; Franziska Righini-Grunder; Osvaldo Borrelli
Journal:  Nutrients       Date:  2021-06-19       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.